Publications by authors named "Barbara Howe"

Claim this Profile
H
Health-Related Quality of Life in Adolescents and Adults With Cystic Fibrosis: Physical and Mental Health Predictors.
Jennifer A Cronly, Alistair J Duff, Kristin A Riekert, Anthony P Fitzgerald, Ivan J Perry, Barbara A Howe

Respir Care· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Positive mental health and wellbeing in adults with cystic fibrosis: A cross sectional study.
Jennifer Cronly, Alistair Duff, Kristin Riekert, Aine Horgan, Elaine Lehane, Barbara Howe

J Psychosom Res· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Online versus paper-based screening for depression and anxiety in adults with cystic fibrosis in Ireland: a cross-sectional exploratory study.
Jennifer Cronly, Alistair J Duff, Kristin A Riekert, Ivan J Perry, Anthony P Fitzgerald, Barbara Howe

BMJ Open· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of a regulatory agency enquiry into potential porcine circovirus type 1 contamination of the human rotavirus vaccine, Rotarix: approach and outcome.
Gary Dubin, Jean-François Toussaint, Jean-Pol Cassart, Barbara Howe, Donna Boyce

Hum Vaccin Immunother· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccination of adults 65 years of age and older with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Boostrix(®)): results of two randomized trials.
Wayde M Weston, Leonard R Friedland, Xiangfeng Wu, Barbara Howe

Vaccine· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An open-label, randomized, multi-center study of the immunogenicity and safety of DTaP-IPV (Kinrix™) co-administered with MMR vaccine with or without varicella vaccine in healthy pre-school age children.
Nicola P Klein, Wayde M Weston, Sherine Kuriyakose, Devayani Kolhe, Barbara Howe

Vaccine· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistence of antibodies 3 years after booster vaccination of adults with combined acellular pertussis, diphtheria and tetanus toxoids vaccine.
Wayde Weston, Marc Messier, Leonard R Friedland, Xiangfeng Wu, Barbara Howe

Vaccine· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and reactogenicity of co-administered tetanus-diphtheria-acellular pertussis (Tdap) and tetravalent meningococcal conjugate (MCV4) vaccines compared to their separate administration.
Wayde M Weston, Leonard R Friedland, Xiangfeng Wu, Barbara Howe

Vaccine· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-marketing safety evaluation of a tetanus toxoid, reduced diphtheria toxoid and 3-component acellular pertussis vaccine administered to a cohort of adolescents in a United States health maintenance organization.
Nicola P Klein, John Hansen, Edwin Lewis, Liisa Lyon, Bessie Nguyen, Barbara Howe

Pediatr Infect Dis J· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of a tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine when co-administered with influenza vaccine in adults.
Wayde M Weston, Vijayalakshmi Chandrashekar, Leonard R Friedland, Barbara Howe

Hum Vaccin· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and safety of a tetanus toxoid, reduced diphtheria toxoid and three-component acellular pertussis vaccine in adults 19-64 years of age.
Mark Blatter, Leonard R Friedland, Wayde M Weston, Ping Li, Barbara Howe

Vaccine· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization.
Kenneth M Zangwill, Eileen Eriksen, Martin Lee, Jennifer Lee, S Michael Marcy, Barbara Howe

Pediatrics· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diphtheria-tetanus-acellular pertussis and inactivated poliovirus vaccines given separately or combined for booster dosing at 4-6 years of age.
Steven Black, Leonard R Friedland, Kathleen Ensor, Wayde M Weston, Barbara Howe

Pediatr Infect Dis J· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of reduced antigen content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine.
Fred Zepp, Pirmin Habermehl, Markus Knuf, Wilma Mannhardt-Laakman, Barbara Howe

Vaccine· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of reduced-antigen-content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine.
Fred Zepp, Markus Knuf, Pirmin Habermehl, Wilma Mannhardt-Laakmann, Barbara Howe

J Pediatr· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and safety of a combined DTaP-IPV vaccine compared with separate DTaP and IPV vaccines when administered as pre-school booster doses with a second dose of MMR vaccine to healthy children aged 4-6 years.
Steven Black, Leonard R Friedland, Anne Schuind, Barbara Howe,

Vaccine· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum antibody responses after intradermal vaccination against influenza.
Robert B Belshe, Frances K Newman, Joan Cannon, Carol Duane, John Treanor, Barbara J Howe

N Engl J Med· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of a birth dose of hepatitis B vaccine on the reactogenicity and immunogenicity of diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b combination vaccination.
Michael E Pichichero, Mark M Blatter, Keith S Reisinger, Christopher J Harrison, Candice E Johnson, Barbara J Howe

Pediatr Infect Dis J· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of a combination diphtheria-tetanus toxoids-acellular pertussis-hepatitis B vaccine administered at two, four and six months of age compared with monovalent hepatitis B vaccine administered at birth, one month and six months of age.
David P Greenberg, Victor K Wong, Susan Partridge, Barbara J Howe, Joel I Ward

Pediatr Infect Dis J· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interchangeability of 2 diphtheria-tetanus-acellular pertussis vaccines in infancy.
David P Greenberg, Larry K Pickering, Shelly D Senders, Jeffrey D Bissey, Robert A Howard, Barbara J Howe

Pediatrics· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis